On Invalid Date, Allarity Therapeutics (NASDAQ: ALLR) reported Q4 2022 earnings per share (EPS) of -$8.05, up 90.76% year over year. Total Allarity Therapeutics earnings for the quarter were -$3.10 million. In the same quarter last year, Allarity Therapeutics's earnings per share (EPS) was -$87.15.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.